Curebound added Paula Schneider and Richard Whittington to its Board of Directors

Curebound is a San Diego-based 501c3 philanthropic organization that raises and invests strategic funding into innovative cancer research projects aimed at accelerating new discoveries to viable options for patients who need them today. Uniting two highly respected local organizations – Padres Pedal the Cause and the Immunotherapy Foundation under one banner, Curebound has collectively raised over $43 million to fund more than 142 collaborative cancer research initiatives across San Diego’s exceptional research institutions including: UC San Diego Health, Rady Children’s Hospital, Salk Institute, Sanford Burnham Prebys, La Jolla Institute for Immunology and Scripps Research. Over the next decade, Curebound is committed to investing $100 million into game-changing cancer research in to improve the lives of patients and accelerate research into cures. Under the expert leadership of the Scientific Advisory Board, Curebound seeks out the most promising areas of opportunity for research across these five pillars: • Prevention and diagnostic tools • Novel approaches and new therapeutic platforms • Immunotherapies and personalized vaccines • Addressing cancer disparities • Pediatric cancers Curebound is founded on the deeply held belief that cures are possible and a vision of a world without cancer. We invite you to learn more and connect with us at curebound.org